TCL Archive Nutrition May Get An Extra 44 Million In FY 1979; Program Announcement Describes Opportunities September 22, 1978
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014